NPPB and diabetes mellitus: Regarding MRBs, the ARTS-HF study reported that 30–40% of HF patients with diabetes mellitus and/or chronic kidney disease treated with eplerenone or finerenone presented with a >30% reduction of NT-proBNP [22].